Agency Forms Undergoing Paperwork Reduction Act Review, 15366-15367 [2013-05520]
Download as PDF
<![CDATA[
15366
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Notices
Additional Information
Additional information about the
project is available from the
Commission’s Office of External Affairs,
at (866) 208–FERC, or on the FERC Web
site at www.ferc.gov using the
‘‘eLibrary’’ link. Click on the eLibrary
link, click on ‘‘General Search’’ and
enter the docket number, excluding the
last three digits in the Docket Number
field (i.e., CP13–64). Be sure you have
selected an appropriate date range. For
assistance, please contact FERC Online
Support at FercOnlineSupport@ferc.gov
or toll free at (866) 208–3676, or for
TTY, contact (202) 502–8659. The
eLibrary link also provides access to the
texts of formal documents issued by the
Commission, such as orders, notices,
and rulemakings.
In addition, the Commission now
offers a free service called eSubscription
which allows you to keep track of all
formal issuances and submittals in
specific dockets. This can reduce the
amount of time you spend researching
proceedings by automatically providing
you with notification of these filings,
document summaries, and direct links
to the documents. Go to www.ferc.gov/
esubscribenow.htm.
Finally, public meetings or site visits
will be posted on the Commission’s
calendar located at www.ferc.gov/
EventCalendar/EventsList.aspx along
with other related information.
Dated: March 4, 2013.
Kimberly D. Bose,
Secretary.
[FR Doc. 2013–05550 Filed 3–8–13; 8:45 am]
BILLING CODE 6717–01–P
DEPARTMENT OF ENERGY
Federal Energy Regulatory
Commission
[ Project No. 14497–000]
mstockstill on DSK4VPTVN1PROD with NOTICES
Archon Energy 1, Inc.; Notice of
Preliminary Permit Application
Accepted for Filing and Soliciting
Comments, Motions To Intervene, and
Competing Applications
On February 11, 2013, the Archon
Energy 1, Inc., filed an application for
a preliminary permit, pursuant to
section 4(f) of the Federal Power Act
(FPA), proposing to study the feasibility
of the Kings River Drop 3 Hydroelectric
Project (Kings river Drop 3 Project or
project) to be located on Kings River,
near the city of Sanger, Fresno County,
California. The sole purpose of a
preliminary permit, if issued, is to grant
the permit holder priority to file a
license application during the permit
VerDate Mar<15>2010
16:19 Mar 08, 2013
Jkt 229001
term. A preliminary permit does not
authorize the permit holder to perform
any land-disturbing activities or
otherwise enter upon lands or waters
owned by others without the owners’
express permission.
The proposed project would consist of
the following: (1) A VLH diversion canal
intake and a gated turbine structure
adjacent to the eastern abutment of the
existing dam; (2) a 300-foot by 60-foot
turbine structure enclosing three VLH
4000 turbo generators; (3) a 10 foot by
10 foot electrical control shack; and (4)
appurtenant facilities. The proposed
project would have a total installed
capacity of 1.5 megawatts (MW) and
generate an estimated average annual
energy production of 10,000 megawatthours (MWh) by diverting existing
stream flow into the diversion canal.
Applicant Contact: Mr. Paul Grist,
Archon Energy 1, Inc., 101 E. Kennedy
Blvd., Suite 2800, Tampa, Florida
33602, phone: (403) 618–2018.
FERC Contact: Kenneth Hogan;
phone: (202) 502–8434, email:
kenneth.hogan@ferc.gov.
Deadline for filing comments, motions
to intervene, competing applications
(without notices of intent), or notices of
intent to file competing applications: 60
days from the issuance of this notice.
Competing applications and notices of
intent must meet the requirements of 18
CFR 4.36. Comments, motions to
intervene, notices of intent, and
competing applications may be filed
electronically via the Internet. See 18
CFR 385.2001(a)(1)(iii) and the
instructions on the Commission’s Web
site https://www.ferc.gov/docs-filing/
efiling.asp. Commenters can submit
brief comments up to 6,000 characters,
without prior registration, using the
eComment system at https://
www.ferc.gov/docs-filing/
ecomment.asp. You must include your
name and contact information at the end
of your comments. For assistance,
please contact FERC Online Support at
FERCOnlineSupport@ferc.gov or toll
free at 1–866–208–3676, or for TTY,
(202) 502–8659. Although the
Commission strongly encourages
electronic filing, documents may also be
paper-filed. To paper-file, mail an
original and seven copies to: Kimberly
D. Bose, Secretary, Federal Energy
Regulatory Commission, 888 First Street
NE., Washington, DC 20426.
More information about this project,
including a copy of the application, can
be viewed or printed on the ‘‘eLibrary’’
link of Commission’s Web site at
https://www.ferc.gov/docs-filing/
elibrary.asp. Enter the docket number
(P–14497) in the docket number field to
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
access the document. For assistance,
contact FERC Online Support.
Dated: March 4, 2013.
Kimberly D. Bose,
Secretary.
[FR Doc. 2013–05549 Filed 3–8–13; 8:45 am]
BILLING CODE 6717–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–13–12RS]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
Proposed Project
Exposure Assessment and
Epidemiological Study of U.S. Workers
Exposed to Carbon Nanotubes and
Carbon Nanofibers—New—National
Institute for Occupational Safety and
Health (NIOSH), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The mission of the National Institute
for Occupational Safety and Health
(NIOSH) is to promote safety and health
at work for all people through research
and prevention. The Occupational
Safety and Health Act of 1970, Public
Law 91–596 (Section 20[a][1] authorizes
NIOSH to conduct research to advance
the health and safety of workers. In this
capacity, NIOSH will conduct an
exposure assessment and
epidemiological study of U.S. carbon
nanotube (CNT) and carbon nanofiber
(CNF) workers.
At present, because of the newness of
the technology, much of the
occupational exposure to engineered
nanomaterials occurs at the research
and development (R&D) or pilot scale.
There have been few reliable surveys of
the size of the workforce exposed to
nanomaterials. Health effects from
exposure to nanomaterials are
uncertain, but may be more severe than
E:\FR\FM\11MRN1.SGM
11MRN1
15367
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Notices
from larger-sized particles of the same
material. This is due to the small size,
high surface area per unit mass (i.e.,
specific surface area) or (in some cases)
high aspect ratio of nanomaterials.
Carbon nanotubes and nanofibers are
among the nanomaterials of greatest
interest from a public health perspective
because of their potentially asbestiform
properties (e.g., high aspect ratio) and
toxicological evidence of possible
fibrogenic, inflammatory, and
clastogenic damage resulting from
exposures at occupationally relevant
levels. In addition, the useful properties
of CNT and CNF have rendered them
among the first nanomaterials to be
commercially exploited in
manufacturing settings. Thus, an
epidemiologic study to determine
whether early or late health effects
occur from occupational exposure to
CNT and CNF is warranted.
The proposed research is a crosssectional study of the small current U.S.
workforce involved with CNT and CNF
in manufacturing and distribution, to be
conducted in the following phases: (1)
Industrywide exposure assessment
study to evaluate worker exposure and
further develop and refine measurement
methods for CNT and CNF. This
component will refine sampling and
analysis protocols previously developed
for the detection and quantification of
CNT and CNF in US workplaces. 2) A
cross-sectional study relating the best
metrics of CNT and CNF exposure to
markers of early pulmonary or
cardiovascular health effects. After the
sampling and analysis protocols have
been established to measure CNT and
CNF, an industrywide study of the
association between exposure and
health effects will be conducted.
Medical examinations will be
conducted and several biomarkers of
early effect (for pulmonary fibrosis,
cardiovascular disease, and genetic
damage) will be measured in blood and
sputum for workers exposed to a range
of CNT and CNF levels.
The study will include a
questionnaire with a three-fold purpose:
(1) To determine whether study
participants have any contraindications
for certain medical procedures to be
conducted (spirometry and sputum
induction), (2) to assist in interpretation
of the biomarker results, and (3) to
inquire about current and past exposure
to CNT, CNF, and other chemicals,
dusts, and fumes. The questionnaire
will be given by NIOSH personnel as a
computer-assisted personal interview
(CAPI). After administration of the
CAPI, medical examinations will be
conducted to evaluate pulmonary
function (via spirometry) and blood
pressure, and sputum and blood will be
collected. Statistical analyses will be
conducted to determine the nature of
the relation between exposure to CNT
and CNF and these biomarkers of early
effect, considering potential
confounding factors such as smoking,
age, gender, and workplace coexposures, including non-engineered
ultrafine particles.
The proposed project supports the
NIOSH legislatively mandated
industrywide studies program that
conducts epidemiological and exposure
assessment research studies to identify
the occupational causes of disease in the
working population and their offspring
and to effectively communicate study
results to workers, scientists, industry,
and the public.
The questionnaire will be
administered one time only, at the
worksite, to 100 workers involved in the
production and use of CNT or CNT, over
a three-year period. The study will be
carried out during the participants’
regular work shift. There is no cost to
respondents or their employers other
than their time. We estimate that the
average burden per response to be 22
minutes for the questionnaire and 20
minutes for the consent form. There are
no costs to respondents other than their
time. The total estimated annual burden
hours are 23.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Nanomaterials Workers ..................................
Nanomaterials Workers ..................................
Questionnaire .................................................
Informed Consent ...........................................
Dated: February 28, 2013.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI),
Office of the Associate Director for Science
(OADS), Office of the Director, Centers for
Disease Control and Prevention.
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
[FR Doc. 2013–05520 Filed 3–8–13; 8:45 am]
BILLING CODE 4163–18–P
mstockstill on DSK4VPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Proposed Project
[30Day-13–0739]
CDC Oral Health Management
Information System (OMB No. 0920–
0739, exp. 5/31/2013)—Extension—
National Center for Chronic Disease
Prevention and Public Health Promotion
(NCDDPHP), Centers for Disease Control
and Prevention (CDC).
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
VerDate Mar<15>2010
16:19 Mar 08, 2013
Jkt 229001
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
33
33
Average
burden per
response
(in hours)
1
1
22/60
20/60
Background and Brief Description
The CDC seeks to improve the oral
health of the nation by targeting efforts
to improve the infrastructure of state
and territorial oral health departments,
strengthen and enhance program
capacity related to monitoring the
population’s oral health status and
behaviors, develop effective programs to
improve the oral health of children and
adults, evaluate program
accomplishments, and inform key
stakeholders, including policy makers,
of program results. Through a
cooperative agreement program
(Program Announcement DP08–802 and
DP10–1012), CDC has provide
approximately $5 million per year over
five years to 20 states to strengthen their
core oral health infrastructure and
capacity. CDC funding also helps states
reduce health disparities among high-
E:\FR\FM\11MRN1.SGM
11MRN1
]]>Agencies
[Federal Register Volume 78, Number 47 (Monday, March 11, 2013)]
[Notices]
[Pages 15366-15367]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-05520]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-13-12RS]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
(404) 639-7570 or send an email to omb@cdc.gov. Send written comments
to CDC Desk Officer, Office of Management and Budget, Washington, DC
20503 or by fax to (202) 395-5806. Written comments should be received
within 30 days of this notice.
Proposed Project
Exposure Assessment and Epidemiological Study of U.S. Workers
Exposed to Carbon Nanotubes and Carbon Nanofibers--New--National
Institute for Occupational Safety and Health (NIOSH), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The mission of the National Institute for Occupational Safety and
Health (NIOSH) is to promote safety and health at work for all people
through research and prevention. The Occupational Safety and Health Act
of 1970, Public Law 91-596 (Section 20[a][1] authorizes NIOSH to
conduct research to advance the health and safety of workers. In this
capacity, NIOSH will conduct an exposure assessment and epidemiological
study of U.S. carbon nanotube (CNT) and carbon nanofiber (CNF) workers.
At present, because of the newness of the technology, much of the
occupational exposure to engineered nanomaterials occurs at the
research and development (R&D) or pilot scale. There have been few
reliable surveys of the size of the workforce exposed to nanomaterials.
Health effects from exposure to nanomaterials are uncertain, but may be
more severe than
[[Page 15367]]
from larger-sized particles of the same material. This is due to the
small size, high surface area per unit mass (i.e., specific surface
area) or (in some cases) high aspect ratio of nanomaterials. Carbon
nanotubes and nanofibers are among the nanomaterials of greatest
interest from a public health perspective because of their potentially
asbestiform properties (e.g., high aspect ratio) and toxicological
evidence of possible fibrogenic, inflammatory, and clastogenic damage
resulting from exposures at occupationally relevant levels. In
addition, the useful properties of CNT and CNF have rendered them among
the first nanomaterials to be commercially exploited in manufacturing
settings. Thus, an epidemiologic study to determine whether early or
late health effects occur from occupational exposure to CNT and CNF is
warranted.
The proposed research is a cross-sectional study of the small
current U.S. workforce involved with CNT and CNF in manufacturing and
distribution, to be conducted in the following phases: (1) Industrywide
exposure assessment study to evaluate worker exposure and further
develop and refine measurement methods for CNT and CNF. This component
will refine sampling and analysis protocols previously developed for
the detection and quantification of CNT and CNF in US workplaces. 2) A
cross-sectional study relating the best metrics of CNT and CNF exposure
to markers of early pulmonary or cardiovascular health effects. After
the sampling and analysis protocols have been established to measure
CNT and CNF, an industrywide study of the association between exposure
and health effects will be conducted. Medical examinations will be
conducted and several biomarkers of early effect (for pulmonary
fibrosis, cardiovascular disease, and genetic damage) will be measured
in blood and sputum for workers exposed to a range of CNT and CNF
levels.
The study will include a questionnaire with a three-fold purpose:
(1) To determine whether study participants have any contraindications
for certain medical procedures to be conducted (spirometry and sputum
induction), (2) to assist in interpretation of the biomarker results,
and (3) to inquire about current and past exposure to CNT, CNF, and
other chemicals, dusts, and fumes. The questionnaire will be given by
NIOSH personnel as a computer-assisted personal interview (CAPI). After
administration of the CAPI, medical examinations will be conducted to
evaluate pulmonary function (via spirometry) and blood pressure, and
sputum and blood will be collected. Statistical analyses will be
conducted to determine the nature of the relation between exposure to
CNT and CNF and these biomarkers of early effect, considering potential
confounding factors such as smoking, age, gender, and workplace co-
exposures, including non-engineered ultrafine particles.
The proposed project supports the NIOSH legislatively mandated
industrywide studies program that conducts epidemiological and exposure
assessment research studies to identify the occupational causes of
disease in the working population and their offspring and to
effectively communicate study results to workers, scientists, industry,
and the public.
The questionnaire will be administered one time only, at the
worksite, to 100 workers involved in the production and use of CNT or
CNT, over a three-year period. The study will be carried out during the
participants' regular work shift. There is no cost to respondents or
their employers other than their time. We estimate that the average
burden per response to be 22 minutes for the questionnaire and 20
minutes for the consent form. There are no costs to respondents other
than their time. The total estimated annual burden hours are 23.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Nanomaterials Workers................. Questionnaire........... 33 1 22/60
Nanomaterials Workers................. Informed Consent........ 33 1 20/60
----------------------------------------------------------------------------------------------------------------
Dated: February 28, 2013.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI), Office of the Associate
Director for Science (OADS), Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2013-05520 Filed 3-8-13; 8:45 am]
BILLING CODE 4163-18-P
